product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Ubc13 Antibody
catalog :
4919S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/DilutionReference
  • western blot (knockdown validation); human; fig 1
Thorslund T, Ripplinger A, Hoffmann S, Wild T, Uckelmann M, Villumsen B, et al. Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage. Nature. 2015;527:389-93 pubmed publisher
  • western blot; human; fig s3
Ahn J, Kim S, Na W, Baek S, Kim J, Min K, et al. SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase. Nucleic Acids Res. 2015;43:6321-33 pubmed publisher
  • western blot; human
Poulsen S, Hansen R, Wagner S, van Cuijk L, van Belle G, Streicher W, et al. RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response. J Cell Biol. 2013;201:797-807 pubmed publisher
product information
SKU :
4919S
Product-Name :
Ubc13 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
16
Host :
Rabbit
Target :
UBE2N
Primary-Protein :
UBE2N
Alt-Names :
BLU,Bendless-like ubiquitin-conjugating enzyme,MGC131857,MGC8489,UBE2N,Ubc13,UbcH-ben,Ubiquitin carrier protein N,Ubiquitin-conjugating enzyme E2 N,Ubiquitin-protein ligase N,bendless-like ubiquitin conjugating enzyme,ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast),ubiquitin-conjugating enzyme E2N (homologous to yeast UBC13),yeast UBC13 homolog
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.